A method for preparing pyrazolo[1,5-c]quinazoline skeleton compounds in copper-catalyzed aqueous phase
A technology for the preparation of skeleton compounds and aqueous phases, which is applied in the field of preparation of pyrazolo[1,5-c]quinazoline compounds, which can solve the problems of harsh reaction conditions, numerous steps, and long reaction time, and achieve side reactions less, wide application range, and easy operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0019]
[0020] Unsubstituted quinazoline N,N-dipolar compound A (0.2mmol) and 10mmol% CuSO 4 ·5H 2 O was placed in a 25mL Schlenk tube, under nitrogen protection, phenylacetylene (0.4mmol) and DBU (2.0equiv) were added at room temperature. After 12 hours of reaction, TLC tracked and detected that the reaction was complete. After the reaction, the reaction solution was cooled to room temperature. The reaction solution was extracted with ethyl acetate (3×10mL), and the organic phases were combined with MgSO 4 After drying, spin the solvent under reduced pressure with a rotary evaporator, concentrate the reaction solution and separate it by column chromatography with a 1:8 (EA:PE) developing solvent to obtain the corresponding 2-phenyl-pyrazolo[1,5-c ]Quinazoline 2a, white solid, yield 80%, m.p.: 155-156 o c.
[0021] 1 H NMR (400 MHz, CDCl 3 ) : δ(ppm) 9.09 (s, 1H), 7.85 (d, J = 7.6 Hz,1H), 7.94-7.97 (m, 3H), 7.60 (m, 2H), 7.46 (d, J = 8.4 Hz, 2H), 7.21 (s, 1H).
...
example 2
[0027]
[0028] unsubstituted quinazoline N,N- Dipolar Compound A (0.2mmol) and 10mmol% CuSO 4 ·5H 2 O was placed in a 25mL Schlenk tube, and p-methoxyphenylacetylene (0.4mmol) and DBU (2.0equiv) were added at room temperature under nitrogen protection. After 12 hours of reaction, TLC tracked and detected that the reaction was complete. After the reaction, the reaction solution was After cooling to room temperature, the reaction solution was extracted with ethyl acetate (3×10 mL), and the combined organic phases were washed with MgSO 4 After drying, use a rotary evaporator to spin dry the solvent under reduced pressure. After concentrating the reaction solution, the corresponding 2-(4-methoxy-phenyl)-pyrazolo[1,5-c]quinazoline was separated by column chromatography with 1:8 (EA:PE) developing solvent 2b, white solid, yield 73%, m.p.: 145-147 o c.
[0029] 1 H NMR (400 MHz, CDCl 3 ) : δ(ppm) 9.09 (s, 1H) ,8.05 (d, J = 7.6 Hz,1H), 7.93-7.96 (m, 3H), 7.60-7.66 (m, 2H...
example 3
[0033]
[0034] unsubstituted quinazoline N,N- Dipolar Compound A (0.2mmol) and 10mmol% CuSO 4 ·5H 2 O is placed in a 25mL Schlenk tube, under nitrogen protection, p-bromophenylacetylene (0.4mmol) and DBU (2.0equiv) are added at room temperature. After 12 hours of reaction, TLC tracking detects that the reaction is complete. After the reaction, the reaction solution is cooled to At room temperature, the reaction solution was extracted with ethyl acetate (3×10 mL), and the combined organic phases were washed with MgSO 4 After drying, use a rotary evaporator to spin dry the solvent under reduced pressure. After concentrating the reaction solution, the corresponding 2-(4-bromo-phenyl)-pyrazolo[1,5-c]quinazoline 2c was obtained by column chromatography using a 1:8 (EA:PE) developing solvent. White solid, yield 79%, m.p.: 216-218 o c.
[0035] 1 H NMR (400 MHz, CDCl 3 ) : δ(ppm) 9.10 (s, 1H), 8.06 (d, J = 7.8Hz,1H), 7.96 (d, J = 8.2 Hz, 1H), 7.89 (d, J = 8.6 Hz, 2H...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 
![A method for preparing pyrazolo[1,5-c]quinazoline skeleton compounds in copper-catalyzed aqueous phase](https://images-eureka.patsnap.com/patent_img/dd1dc32b-207c-4c0d-b9c5-4b689d03600e/DEST_PATH_IMAGE001.png)
![A method for preparing pyrazolo[1,5-c]quinazoline skeleton compounds in copper-catalyzed aqueous phase](https://images-eureka.patsnap.com/patent_img/dd1dc32b-207c-4c0d-b9c5-4b689d03600e/DEST_PATH_IMAGE002.png)
![A method for preparing pyrazolo[1,5-c]quinazoline skeleton compounds in copper-catalyzed aqueous phase](https://images-eureka.patsnap.com/patent_img/dd1dc32b-207c-4c0d-b9c5-4b689d03600e/DEST_PATH_IMAGE003.png)